Código QR (código de barras bidimensional)

Pembrolizumab on pre-existing inclusion body myositis: a case report

Abstract Background Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased risk of exacerbation. We describe the...

ver descrição completa

Na minha lista:
Principais autores: Naohiro Uchio, Atsushi Unuma, Toshiyuki Kakumoto, Masao Osaki, Yoshitaka Zenke, Kenichi Sakuta, Akatsuki Kubota, Yoshikazu Uesaka, Tatsushi Toda, Jun Shimizu
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-09-01
coleção:BMC Rheumatology
Assuntos:
Inclusion body myositis
Immune checkpoint
Pembrolizumab
Immune-related adverse events
Acesso em linha:http://link.springer.com/article/10.1186/s41927-020-00144-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados